POSTER SESSION V
Wednesday, March 24, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
172
Array Comparative Genomic Hybridization Identifies Genetic Changes Exclusive to Chemotherapy-Refractory or Chemotherapy-Responsive Diffuse Large B-Cell Lymphomas
(1373)
F Kreisel, S Kulkarni, R Kerns, H Deshmukh, R Nagarajan, A Hassan, J Frater, A Cashen - Washington University, Saint Louis, MO
Prevalence and Prognostic Significance of 1p36 Microdeletions in Non-Hodgkin B Cell Lymphomas
(1338)
A Gru, F Kreisel, T Nguyen, JL Frater, A Hassan - Washington University in St. Louis, Saint Louis, MO
Clinical Impact of MYC, BCL2, BCL6, and MALT1 Alterations in Diffuse Large B-Cell Lymphoma in the Rituximab Era
(1456)
S Valera, T Cardesa, F Climent, V Romagosa, E Gonzalez, L Arenillas, S Serrano, JL Mate, O Salamero, A Lopez-Guillermo, E Campo, L Colomo - H. Clinic, Barcelona, Spain; H. de Bellvitge, Barcelona, Spain; H. del Mar, Barcelona, Spain; H. Germans Tries, Badalona, Grup Estudi Limfomes Catalunya i Balears, Spain
MYC, BCL6 and BCL2 Genetic Alterations and Associated Phenotypes of AIDS-Related Diffuse Large B Cell Lymphomas Suggest Biologic Differences with Immunocompetent DLBCLs
(1387)
S Mathew, S Gogineni, E Cesarman, DM Knowles, A Chadburn - Weill Cornell Medical College, New York, NY; Northwestern University Feinberg School of Medicine, Chicago, IL
BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas
(1271)
N Akyurek, A Uner, M Benekli, I Barista - Gazi University, Medical Faculty, Ankara, Turkey; Hacettepe University, Medical Faculty, Ankara, Turkey
Altered Subcellular Localization of the c-Myc Protein Distinguishes Burkitt Lymphoma from Aggressive B-Cell Lymphomas without a c-MYC Translocation
(1428)
MB Ruzinova, T Caron, SJ Rodig - Brigham and Women's Hospital, Boston, MA
Genome Wide Analysis of Burkitt Lymphoma and Lymphomas Intermediate between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma by Single Nucleotide Polymorphism Array
(1334)
JF Gradowski, B Van Oss, U Chandran, L Finn, E Jacob, SH Swerdlow - University of Pittsburgh Medical School, Pittsburgh, PA; University of Pittsburgh Medical Center, Pittsburgh, PA; Seattle Children's Hospital, Seattle, WA
Recurrent Chromosomal Aberrations in High Grade B-Cell Lymphomas with IG-MYC Rearrangement and Their Impact on Diagnosis and Survival
(1326)
R Garcia, AC Seegmiller, A Maleki, R Huang, C Tirado, W Chen - UT Southwestern Medical Center at Dallas, Dallas, TX
Diffuse Large B-Cell Lymphomas with High Grade Morphologic Featues and/or MYC Translocations Lack Distinctive Clinicopathologic Features at Presentation: A SWOG S9704 Study
(1308)
JR Cook, RR Tubbs, B Goldman, M Leblanc, L Rimsza, R Fisher, P Stiff - Cleveland Clinic, Cleveland, OH; Fred Hutchinson Cancer Center, Seattle, WA; Univ. of Arizona, Tuscon, AZ; Univ. of Rochester, Rochester, NY; Loyola Univ., Chicago, IL
Large B-Cell Lymphoma Initially Presenting in Bone Marrow, Liver and Spleen: An Aggressive Entity Frequently Associated with Hemophagocytic Syndrome
(1301)
KC Chang, CC Chen, IC Liao, SY Tsai, DM Jones - National Cheng Kung University, Tainan, Taiwan; The University of Texas MD Anderson Cancer Center, Houston, TX
Significance of the Level of CD20 Expression Determined by Mean Fluorescence Intensity Ratio Using Flow Cytometry in Diffuse Large B-Cell Lymphoma
(1436)
M Shahjahan, NJ Nelles, Y Feng, Y Zu, A Ewton, CC Chang - The Methodist Hospital, Houston, TX
BCL-6 Expression and Hans'Algorithm Are Able To Predict Patients' Outcome in Extranodal Diffuse Large B-Cell Lymphomas
(1454)
S Uccella, I Ricotti, S Freguia, R Invernizzi, I Proserpio, G Pinotti, C Capella - University of Insubria, Varese, Italy; Ospedale di Circolo-University of Insubria, Varese, Italy
Most T-Cell/Histiocyte Rich B Cell Lymphomas Express an Activated B-Cell-Like Phenotype and a Pattern of Signaling Molecules That Differ from Other Diffuse Large B-Cell Lymphomas
(1462)
Y Wang, B Petersen, A Lam, I Braunschweig, J Albanese, H Ratech - Albert Einstein College of Medicine, Bronx, NY; Mount Sinai Medical School, NY, NY
Comparing Immunohistochemical Methods for Predicting Gene Expression Profile and Survival of Diffuse Large B-Cell Lymphoma Treated with Rituximab
(1391)
PN Meyer, LM Smith, K Fu, TC Greiner, P Aoun, J Delabie, RD Gascoyne, A Rosenwald, RM Braziel, E Campo, JM Vose, G Lenz, LM Staudt, WC Chan, DD Weisenburger - University of Nebraska Medical Center, Omaha, NE; Leukemia/Lymphoma Molecular Profiling Project, Omaha, NE
Comparison of B-Cell Lineage and Prognostic Markers before and after Therapy with Rituximab-Containing Regimen in Diffuse Large B-Cell Lymphoma and Chronic Lymphocytic Leukemia
(1381)
BM Mahon, Y Chen - Northwestern Memorial Hospital, Chicago, IL
The Stromal Marker Sparc Predicts Survival of Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab
(1390)
PM Meyer, LM Smith, K Fu, TC Greiner, P Aoun, J Delabie, RD Gascoyne, A Rosenwald, RM Braziel, E Campo, JM Vose, G Lenz, LM Staudt, WC Chan, DD Weisenburger - University of Nebraska Medical Center, Omaha, NE; Leukemia/Lymphoma Molecular Profiling Project, Omaha, NE
Hedgehog Signaling Pathway Is Aberrantly Activated in a Subset of High Grade Lymphomas
(1335)
WO Greaves, JE Kim, K Kunkalla, LJ Medeiros, R Singh, F Vega - The University of Texas MD Anderson Cancer Center, Houston, TX; Seoul National University, Boramae Hospital, Seoul, Korea
Increased Expression of the Anti-Apoptotic Protein BAG-3 in High-Grade B Cell Lymphomas and Plasma Cell Myelomas
(1474)
C Zhang, KA Rizzo - Indiana University, Indianapolis, IN
Diffuse Large B-Cell Lymphoma with Overexpression of HSP90 Associate Better Prognosis
(1395)
Z Mo, P Hou, C Goldblatt, L Qian - Conemaugh Memorial Medical Center, Johnstown, PA; Washington University, St Louis, St. Louis, MO
Cyclooxygenase-2 Expression in Diffuse Large B Cell Lymphoma Correlates with Advanced Stage
(1377)
L Li, RK Olson, SM Homan, AM Hayner-Buchan, T Nazeer - Albany Medical Center, Albany, NY
Cyclin-Dependent Kinase Subunit 1B Constitutes an Independent Prognostic Marker in Diffuse Large B-Cell Lymphoma
(1366)
U Keller, S Haug, T Schuster, A Tzankov, S Dirnhofer, M Kremer - Technical University, Munich, Germany; University of Basel, Basel, Switzerland; Klinikum Muenchen, Munich, Germany
Cyclin D1 Positive Diffuse Large B-Cell Lymphomas Feature a Post-Germinal Center - Immunophenotype and Lack Alterations in the CCND1 Gene Locus
(1267)
P Adam, T Vela-Chavez, M Cremer, K Bink, JA Ferry, F Fend, E Jaffe, L Quintanilla-Martinez - University of Tubingen, Tubingen, Germany; Technical University, Munich, Germany; Massachusetts General Hospital, Boston, MA; National Institutes of Health, Bethesda, MD
Expression of CD10, BD6 and MUM1 in Mantle Cell Lymphoma
(1339)
G Gualco, LM Weiss, WJ Harrington, CE Bacchi - Consultoria em Patologia, Botucatu, SP, Brazil; City of Hope National Medical Center, Duarte, CA; University of Miami Miller School of Medicine and Sylvester Cancer Center, Fogarty International Center (AIDS and Tuberculosis Program), Miami, FL
Aberrant Nuclear Expression of β-Catenin Is Associated with Overexpression of Cyclin D1 in Hairy Cell Leukemia
(1325)
J Gao, L Peterson, Y Chen - Northwestern University Feinberg School of Medicine, Chicago, IL
Cyclin D1 Positive Lymphoid Cells in the Proliferation Centers of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Are Not Due to CCND1 Translocations
(1333)
JF Gradowski, R Sargent, FE Craig, SH Swerdlow - University of Pittsburgh School of Medicine, Pittsburgh, PA
Differential Expression of Aurora-A Kinase in Primary Mediastinal (Thymic) Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Involving the Mediastinum
(1437)
RK Shamanna, ME Salama, N Lehman, KV Inamdar - Henry Ford Hospital, Detroit, MI; University of Utah, Salt Lake City, UT
Analysis Aurora-A Kinase Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Lymphoma: Implications in the Regulation of G2/M Phase of Cell Cycle
(1365)
R Kanagal Shamanna, N Lehman, KV Inamdar - Henry Ford Hospital, Detroit, MI
Expressions of Cox-2, Bcl-2 and LMP-1 in Classical Hodgkin's Lymphoma, and Their Relationship with Prognosis
(1355)
G Inan, S Bircan, N Kapucuoglu, N Karahan, M Ciris - Suleyman Demirel University Faculty of Medicine, Isparta, Turkey
Expression of Notch Pathway Proteins in Hodgkin/Reed-Sternberg Cells of Classical Hodgkin Lymphoma
(1419)
D Rakheja, P Kapur, W Chen - UT Southwestern Medical Center, Dallas, TX
Glioma-Associated Oncogene Homologue-3: A Novel Marker for Classical Hodgkin Lymphoma
(1336)
WO Greaves, JE Kim, K Kunkalla, LJ Medeiros, R Singh, F Vega - The University of Texas MD Anderson Cancer Center, Houston, TX; Seoul National University, Boramae Hospital, Seoul, Korea
Increased Expression of Fatty Acid Synthetic Enzymes in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Lymphoma
(1432)
AC Seegmiller, SJ Olson, P Kapur, D Rakheja, W Chen - Vanderbilt University Medical Center, Nashville, TN; University of Texas Southwestern Medical Center, Dallas, TX
Detection of Immunoglobin Heavy Chain Gene Rearrangements in Nodular Lymphocyte Predominant Hodgkin Lymphoma Using Commercially Available BIOMED-2 Primers
(1290)
WK Brix, GC Bullock, DM Haverstick, RM Seaner, LM Silverman, MS Mahadevan, JC Cousar - University of Virginia, Charlottesville, VA
Detection of Clonality in Hodgkin Lymphoma Following the BIOMED-2 Protocol: A Study on Paraffin-Embedded Tissue
(1385)
JL Mate, G Tapia, MD Lopez, MT Fernandez-Figueras, C Sanz, A Ariza - Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Barcelona, Spain
Classical Hodgkin Lymphoma with Expression of T-Cell Markers and Associated T-Cell Receptor Gene Rearrangement - A Separate and More Aggressive Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma?
(1273)
A Alduaij, S Mangray, DO Treaba - Rhode Island Hospital, Lifespan, Providence, RI
High Proportion of Hodgkin-Like Large B-Cell Proliferations Associated with Background Peripheral T-Cell Lymphoma - A Diagnostic Pitfall
(1449)
LHC Tan, AKW Lee, LL Chiu, ESC Koay - Singapore General Hospital, National University Hospital, and National University of Singapore, Singapore, Singapore
Nodular Lymphocyte Predominant Hodgkin Lymphoma: Atypical Morphologic Features Correlate with Clinically Aggressive Disease
(1291)
JT Bunning, U Popat, LJ Medeiros - MD Anderson Cancer Center, Houston, TX
Fibrosis in Nodular Sclerosis Hodgkin Lymphoma Is Predictive of a Residual Mass Following Therapy
(1306)
AJ Church, N Shabazi, DP LeBrun, T Baetz - Queen's University, Kingston, Canada
Solid Organ Cancers Frequently Precede or Co-Occur in Hodgkin Lymphoma of the Elderly
(1285)
G Bard, D Korol, K Rufibach, N Probst-Hensch, S Dehler, MO Kurrer - Cantonal Hospital Aarau, Aarau, Switzerland; University of Zurich, Zurich, Switzerland
button next to any title to add to Itinerary Planner...
Add
